compounded semaglutide risks Patient Safety Updates Navigating Compounded Semaglutide: What Health

[DOI] [PMC free article] [PubMed] [Google Scholar] 50.Nuijten M.A.H., Eijsvogels T.M.H., Monpellier V.M., Janssen I.M.C., Hazebroek E.J., Hopman M.T.E

Because NHIS does not include information on all weight-related conditionssuch as obstructive sleep apnea, peripheral arterial disease, and aortic atherosclerosisthe number and share of the private and ESI markets indicated for GLP-1 drugs are potentially underestimated among those who are overweight

Let us look at the actual data from the most rigorous studies available for each compound, then put them side by side so the differences become unmistakable

99, 2024, OC12.5, Pelusi, Carla, and Renato Pasquali